Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance.
Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance. J Immunol. 2002 May 15; 168(10):5352-8.
View in:
PubMed
subject areas
Acute Disease
Animals
Antibodies, Monoclonal
beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase
B-Lymphocytes
Bone Transplantation
CD40 Ligand
Combined Modality Therapy
Cytokines
Disaccharides
Graft Rejection
Heart Transplantation
Immunoglobulin M
Isoantibodies
Kidney
Mice
Mice, Inbred C3H
Mice, Inbred C57BL
Mice, Inbred DBA
Mice, Knockout
Rats
Rats, Inbred Lew
Swine
T-Lymphocytes
Transplantation Tolerance
Transplantation, Heterologous
Transplantation, Heterotopic
authors with profiles
Anita S. Chong
Dengping Yin